Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Young

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Preventive Medicine|December 17, 2020
Regional differences in perceived treatments needs and priorities in relation to antiretroviral therapy among people living with HIV in 25 countriesChinyere Okoli, Nicolas Van de Velde, Brent Allan, et al.
ATS Scholar|February 18, 2025
Effect of Interventional Pulmonology Fellowships on Pulmonary Critical Care Fellows' Core Bronchoscopy CompetenciesSamiksha Gupta, Christopher Ghiathi, David DiBardino, et al.
Lancet (London, England)|August 8, 2006
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trialJoseph Eron, Patrick Yeni, Joseph Gathe, et al.
The Journal of Antimicrobial Chemotherapy|April 24, 2024
Cardiometabolic health in people with HIV: expert consensus reviewRachel L Batterham, Roger J Bedimo, Ricardo S Diaz, et al.
Trials|April 13, 2023
Impact of the COVID-19 pandemic on a clinical trial of pneumococcal vaccine scheduling (PVS) in rural GambiaIlias Hossain, Isaac Osei, Galega Lobga, et al.
Journal of the International AIDS Society|July 26, 2018
Expert consensus statement on the science of HIV in the context of criminal lawFrançoise Barré-Sinoussi, Salim S Abdool Karim, Jan Albert, et al.
Trials|December 19, 2024
Standardized study performance, quality assurance, and quality control in a cluster-randomized trial: the Pneumococcal Vaccine Schedules trialIsaac Osei, Benjamin Young, Golam Sarwar, et al.
American Journal of Respiratory and Critical Care Medicine|October 2, 2019
A Prediction Model to Help with Oncologic Mediastinal Evaluation for Radiation: HOMERGabriela Martinez-Zayas, Francisco A Almeida, Michael J Simoff, et al.
Lancet (London, England)|January 16, 2010
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trialsJoseph J Eron, Benjamin Young, David A Cooper, et al.
The Lancet. Infectious Diseases|September 22, 2011
Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trialJoseph J Eron, Jürgen K Rockstroh, Jacques Reynes, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Preventive Medicine|December 17, 2020
Regional differences in perceived treatments needs and priorities in relation to antiretroviral therapy among people living with HIV in 25 countriesChinyere Okoli, Nicolas Van de Velde, Brent Allan, et al.
ATS Scholar|February 18, 2025
Effect of Interventional Pulmonology Fellowships on Pulmonary Critical Care Fellows' Core Bronchoscopy CompetenciesSamiksha Gupta, Christopher Ghiathi, David DiBardino, et al.
Lancet (London, England)|August 8, 2006
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trialJoseph Eron, Patrick Yeni, Joseph Gathe, et al.
The Journal of Antimicrobial Chemotherapy|April 24, 2024
Cardiometabolic health in people with HIV: expert consensus reviewRachel L Batterham, Roger J Bedimo, Ricardo S Diaz, et al.
Trials|April 13, 2023
Impact of the COVID-19 pandemic on a clinical trial of pneumococcal vaccine scheduling (PVS) in rural GambiaIlias Hossain, Isaac Osei, Galega Lobga, et al.
Journal of the International AIDS Society|July 26, 2018
Expert consensus statement on the science of HIV in the context of criminal lawFrançoise Barré-Sinoussi, Salim S Abdool Karim, Jan Albert, et al.
Trials|December 19, 2024
Standardized study performance, quality assurance, and quality control in a cluster-randomized trial: the Pneumococcal Vaccine Schedules trialIsaac Osei, Benjamin Young, Golam Sarwar, et al.
American Journal of Respiratory and Critical Care Medicine|October 2, 2019
A Prediction Model to Help with Oncologic Mediastinal Evaluation for Radiation: HOMERGabriela Martinez-Zayas, Francisco A Almeida, Michael J Simoff, et al.
Lancet (London, England)|January 16, 2010
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trialsJoseph J Eron, Benjamin Young, David A Cooper, et al.
The Lancet. Infectious Diseases|September 22, 2011
Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trialJoseph J Eron, Jürgen K Rockstroh, Jacques Reynes, et al.
Pageof 11